IMMUNIC, INC.
Datakwaliteit: 83%
IMUX
Nasdaq
Manufacturing
Chemicals
€ 1,29
▲
€ 0,10
(8,40%)
Marktkapitalisatie: 168,30 M
Prijs
€ 1,29
Marktkapitalisatie
168,30 M
Dagbereik
€ 1,18 — € 1,29
52-Weeksbereik
€ 0,51 — € 1,51
Volume
1.195.171
Openen € 1,18
50D / 200D Gem.
€ 0,98
31,58% above
50D / 200D Gem.
€ 0,84
54,36% above
Quick Summary
Belangrijkste Punten
Negative free cash flow of -85,97 M
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-437,61%
Onder sectorgemiddelde (-53,41%)
ROIC-364,54%
Net MarginN/A
Op. MarginN/A
Veiligheid
Debt / Equity
N/A
Current Ratio1,31
Interest CoverageN/A
Waardering
PE (TTM)
-1,73
Onder sectorgemiddelde (-1,48)
P/B Ratio16,03
EV/EBITDAN/A
Dividend YieldN/A
Koershistorie
Financiële Trends
Sectorvergelijking
vs Manufacturing sector mediaan (1364 peers)
Sectorvergelijking
vs Manufacturing sector mediaan (1364 peers)| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -1,7 | -1,5 |
| P/B | 16,0 | 1,6 |
| ROE % | -437,6 | -53,4 |
| Net Margin % | — | -41,5 |
| Rev Growth 5Y % | — | 1,8 |
| D/E | — | 0,3 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | N/A | Net Income (TTM) | -97,17 M |
| ROE | -437,61% | ROA | -190,29% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -85,97 M |
| ROIC | -364,54% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 1,31 |
| Interest Coverage | N/A | Asset Turnover | N/A |
| Working Capital | 9,19 M | Tangible Book Value | 10,50 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -1,73 | Forward P/E | N/A |
| P/B Ratio | 16,03 | P/S Ratio | N/A |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -51,08% | ||
| Market Cap | 168,30 M | Enterprise Value | 133,17 M |
| Per Share | |||
| EPS (Diluted TTM) | -0,62 | Revenue / Share | N/A |
| FCF / Share | -0,66 | OCF / Share | -0,66 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | 88,47% |
| SBC-Adj. FCF | -95,43 M | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Net Income | -97,17 M | -100,51 M | -93,61 M | -120,41 M | -92,95 M |
| EPS (Diluted) | -0,62 | -1,00 | -2,11 | -3,78 | -3,93 |
| Gross Profit | — | — | — | — | — |
| Operating Income | -103,23 M | -98,05 M | -99,22 M | -119,49 M | -91,67 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 81,98 M | 80,05 M | 83,22 M | 71,26 M | 61,12 M |
| SG&A Expenses | — | — | — | — | — |
| D&A | 168.000,0 | 134.000,0 | 111.000,0 | 77.000,0 | 85.000,0 |
| Interest Expense | — | — | — | — | — |
| Income Tax | 0,0 | — | — | — | — |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 24,05 M | 40,87 M | 54,30 M | 127,75 M | 139,10 M |
| Total Liabilities | 30,73 M | 22,44 M | 25,37 M | 14,07 M | 11,99 M |
| Shareholders' Equity | -6,67 M | 18,43 M | 28,93 M | 113,68 M | 127,12 M |
| Total Debt | — | — | — | — | — |
| Cash & Equivalents | 15,48 M | 35,67 M | 46,67 M | 106,75 M | 86,86 M |
| Current Assets | 22,87 M | 39,33 M | 52,53 M | 125,86 M | 104,99 M |
| Current Liabilities | 30,62 M | 22,18 M | 24,73 M | 13,08 M | 11,40 M |
{"event":"ticker_viewed","properties":{"ticker":"IMUX","listing_kind":"stock","pathname":"/stocks/imux","exchange":"Nasdaq","country":"US"}}